Express-News: UT Health San Antonio signs potential $114M deal with Chinese pharma firm

UT Health San Antonio announced Friday a landmark licensing deal worth up to $114 million with a Chinese pharmaceutical company to develop new treatments for spinal cord injuries and breast cancer.

Read the full story at the Express-News



Share This Article!
Article Categories: Cancer, In the News